OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

TRUSTEES ANNUAL REPORT 2023

Castlepines Medical Foundation

0

Table of Contents

CHAIRMAN’S FOREWORD .................................................................................................................. 2 INTRODUCTION .................................................................................................................................... 3 2023 OVERVIEW ................................................................................................................................... 4 FOCUS ................................................................................................................................................. 4 ACTIVITIES ........................................................................................................................................... 4 ACHIEVEMENTS .................................................................................................................................... 6 CHALLENGES ....................................................................................................................................... 7 IMPACT ................................................................................................................................................ 8 FINANCIAL OVERVIEW ........................................................................................................................ 9 GOVERNANCE AND MANAGEMENT ................................................................................................ 10 FUTURE PLANS .................................................................................................................................. 11 RECOGNITION AND THANKS ........................................................................................................... 11 APPENDIX 1: FINANCIAL SUMMARY ............................................................................................... 12 APPENDIX 2: ANNUAL ACCOUNTS ................................................................................................. 13

1

Trustees Annual Report 2023

For the period from 1[st] January 2023 to 31[st] December 2023

Charity name: Castlepines Medical Foundation Charity registration number: 1187050 Charity address: 36 Pall Mall, St James’s, London, SW1Y 5JN

Trustees:

All Trustees acted for the whole year:

David Grose, Chairman

Neil Carpenter, Secretary

Stanley Shepherd, Treasurer

Tafadzwa Mugwagwa

Ken Ralston

Chairman’s Foreword

2022 had been our year of recovery post Covid during which we planned the restart of the charities activities.

Consequently 2023 was a new beginning and year of renewed learning in which we appointed a new CEO, burnished our governance, created a new strategic plan, visited Zambia and Zimbabwe, and laid the foundations for new projects.

We benefitted greatly from the continuation and extension of our interest free Launch Loan, which was then wholly converted into an unrestricted Launch Donation.

However, post-covid funding for charities has become ever harder to find despite the need being greater.

So there are many challenges ahead.

Nevertheless, our core objective to help those suffering from long term conditions in Africa remains undiluted.

On behalf of all the Trustees I would like to thank our CEO, Louise Normand, for her dedication and contribution on behalf of the charity and her instilling high standards of governance.

2

Introduction

Castlepines Medical Foundation (CMF) was set up in 2019 to address widespread medicine shortages for chronic non-communicable diseases (NCDs) in Africa. The charity was restarted in 2023 following two years of low activity, resulting directly from COVID-19 related risk aversion by UK banks and restrictions on international travel.

During a landscape reassessment trip to Zambia and Zimbabwe in March 2023, it became abundantly clear that the pandemic and recent cholera outbreaks diverted the already limited public health resources further from essential medicines and services for chronic diseases.

In Zimbabwe, our CEO saw first-hand the clinic shelves which had been empty of basic hypertension, diabetes and asthma medicines for months. We spoke with people on long-term prescriptions who were required to buy their own medicines, but due to high pharmacy prices often forego medicines in favour of food and other necessities. Many had stopped going to the clinics altogether and their conditions were left unmanaged, resulting in severe health complications. Since NCDs are most common among the working-age population, this has significant ripple effects on both the health and prosperity of the community.

Sadly, these stories are not isolated. Our team has received raw data which gives an indication of the scale of the shortages for Zimbabwe, and we have spoken with health ministers as far as Nigeria and Zambia who confirm similar situations in other parts of the continent. For medicines which can cost as little as $1 per month it is unthinkable that so many people are suffering.

The urgency of the situation is growing. As a result of changing lifestyles and a growing, ageing population the number of people developing non-communicable diseases is increasing; and is doing so faster in Africa than anywhere else in the world.

History shows us what can be achieved when the international community bands together to address health challenges. By working together, we can reverse the trend of preventable deaths, disabilities, and economic struggles caused by NCDs. However, this transformation hinges on motivated and well-informed public health professionals who currently lack the necessary data to allocate resources effectively toward this issue.

CMF is the only charity in Zimbabwe which is specifically looking to build this necessary evidence base and work with local partners to codevelop long-term sustainable solutions. With a comprehensive understanding of the factors which contribute to medicine shortages and practical experience of addressing them we will show the world how important it is to invest in these overlooked conditions.

Our vision is for everyone in Africa to have access to quality, affordable health services and medicines for long-term chronic and non-communicable diseases.

Our mission is to increase availability of medicines in public facilities and generate data to advocate for greater investment 3 in health services and medicines for people living with NCDs.

2023 Overview

Focus

During the January board meeting, Lou Normand proposed her plans for 2023. The board unanimously agreed with the approach, which encompassed the following elements:

  1. Re-evaluate Project Zambezi last mile drug distribution plans for viability,

  2. Create an operational plan for Project Zambezi based on the outcome of the re-evaluation, and conduct a small-scale proof-of-concept,

  3. Start applying for funding for a pilot project,

  4. Establish governance framework and address historic reporting inconsistencies,

  5. Create a strategic plan for the charity: long-term objectives, short term impact and financing.

Activities

Q1: Castlepines Medical Foundation & Project Zambezi restart

At the first board meeting of the year, Ken Ralston was accepted by the board as a new Trustee for CMF, and Lou Normand presented her proposal to restart the charity’s activities. The overdue 2021 CMF accounts and returns were also discussed and were submitted to the charity commission in February 2023.

Lou accepted the position of CEO in January, with a 01[st] March 2023 start date.

The first activity for the newly appointed CEO was to travel to Zambia and Zimbabwe from 16-29[th] March. The purpose of the trip was primarily to ascertain whether, in light of altered health priorities and the passage of time since Project Zambezi’s inception, shortages of essential medicines remained a substantial and unaddressed concern in Southern Africa.

During the trip the CEO met with key stakeholders who confirmed that the medicine shortages had worsened after the COVID-19 pandemic, and that there were no organisations in Zimbabwe or Zambia which were specifically looking to address the medicine gap for non-communicable diseases. Lou was also provided with survey data which highlighted that, whilst infrequent (every 4 months), the delivery schedule for medicines to public sector facilities was generally reliable.

Q2: Landscape analysis for Project Zambezi

Informal interviews with Zimbabwean ministry officials, supply chain specialists, NGOs and health professionals in Zimbabwe indicated that NCD medicine shortages result from a range of supply chain challenges from source to facility. A lack of data to inform NCD resource allocation was highlighted as a key challenge by the Zimbabwean Ministry of Health.

4

A second trip to Zimbabwe took place in June and provided the CEO with the opportunity to meet with local and international organisations working on NCD projects, and to identify gaps in the NCD space.

As a result of the landscape analysis the Trustees agreed to refocus attention on addressing supply challenges rather than the distribution of medicines in Zimbabwe.

Q3: Castlepines Medical Foundation and Project Zambezi strategy

Having established a thorough understanding of the NCD challenges and priorities in Zimbabwe the CEO formulated a strategy which outlined the short and long-term intentions for Castlepines Medical Foundation, as well as a redefined vision, mission, expected outcomes and impact. In addition, the strategy document defined the evidence-based approach which would be used to achieve long-term sustainability. The Trustees agreed on the importance of alignment with ministry of health priorities and partner-led NCD projects in contributing to systems strengthening efforts.

Subsequently, the CEO drew up a Theory of Change for Project Zambezi which outlines how initial charitable activities align with the long-term charity plans. Project Zambezi was defined as an evidence-generation initiative based in Zimbabwe, the purpose of which is to find a sustainable way to boost the supply of NCD medicines available for dispensing at primary health facilities. The project is comprised of two components: a PhD research project and a small-scale pilot project. Project Zambezi will generate the hard data showing the scale and range of factors which contribute to medicine shortages, and give us practical experience of addressing them in a local context. The project supports the delivery of the World Health Organisation’s Package of Essential NCD interventions (PEN) programme, which is listed alongside data gathering exercises as the greatest priority for the Zimbabwean Ministry of Health NCD department.

Q4: Castlepines Medical Foundation funding, Project Zambezi operational planning

The final quarter of the year was kicked off with an in-person Trustee board meeting in London in addition to the regular mongthly video meetings. The meeting was used to discuss the longer-term strategy for Castlepines Medical Foundation, how the charity would be funded and how the historic launch loan would be repaid.

Regarding the latter; the Trustees agreed that the loan provided by our Chairman to launch the charity would be repaid with only surplus funds generated by the charity once it had a profitable project. There was no expectation that the repayment would begin immediately, the loan was not interest-bearing and had no fixed term.

Historic reporting inaccuracies and previous late submission of accounts and returns to the Charity Commission were addressed, and a plan has been implemented to ensure that deadlines are not missed in the future.

The CEO subsequently returned to Zimbabwe twice more at the end of 2023; both in November and December. The visits were used to meet individuals who would be

5

involved in the running of both the Project Zambezi PhD research project and pilot donations project. The highlight was a visit to the Rushinga district to visit Chimhanda District Hospital and one of the clinics which would be receiving donated hypertension and diabetes medicines through the Project Zambezi pilot.

Achievements

Castlepines Medical Foundation: Reformation and Structuring

Project Zambezi: Restart, Refocus and Refining

6

Challenges

Through the course of the year, challenges were actively identified and addressed or mitigated. External challenges will be familiar to all similar not-for-profit organisations; the greatest of which has been the incredibly competitive fundraising environment in the UK. The major challenges of the past 12 months are outlined below, along with the mitigating actions we have taken and how we see these challenges changing in 2024.

Challenge Challenge Description Mitigations Future Changes
External Fundraising
environment		 There is a
shrinking number
of Trusts and
Foundations in the
UK which support
charities with an
international focus.		 Our fundraising strategy has
been adapted to the current
challenges. We created a
Theory of Change to show
how our work will achieve
positive outcomes. Our
strategy is designed to lead
us to a sustainable funding
model.		 Once our projects are
running we will be able
to measure and report
our progress against
our goals. We believe
this will stand us in
better stead moving
forward.
Pause in CMF
operations
and changing
health
priorities post-
pandemic		 The COVID-19
pandemic changed
the way in which
health conditions
have been
prioritised and
funded in
Zimbabwe, which
had a previously
unknown impact on
the viability of
Project Zambezi
original plans.		 A landscape analysis was
conducted in Zimbabwe in
March & June 2023. It was
concluded that there is an
even greater need for NCD
medicines in Zimbabwe and
nearby countries post-
pandemic, but issues lie
more with medicine supply
than distribution. Project
Zambezi plans were
amended to reflect this.		 CMF communicates
directly with the
Zimbabwean Ministry of
Health and other NCD
partners to understand
changes in funds
available for NCDs and
where the greatest
needs will lie in the
future.
Internal CMF funding
structure		 Historic funding
has always been
from a single
source and was
provided in the
form of a loan.		 Our fundraising strategy is to
establish income streams
from a variety of sources.
The lender for our ‘launch
loan’ has generously offered
to convert the loan to an
unrestricted launch donation
in 2024.		 We will avoid taking on
debt and have a plan to
work towards a
sustainable funding
model which is less
dependent on financial
donations.
CMF historic
reporting
inaccuracies		 A few reporting
inaccuracies were
identified on the
2021 accounts,		 Accounts for both 2020 and
2021 were amended and
(re)submitted to the charities
commission. The 2022		 A plan has been
established with the
Trustees to ensure
future deadlines are

7

and the 2020
accounts were not
submitted on time
due to a
misunderstanding
of reporting needs.		 accounts were submitted on
time. The CMF team are
working with a volunteer
accountant to prepare the
2023 accounts for
submission in Q2 2024.		 well communicated and
the reporting rules are
followed. Accurate
Annual accounts,
Annual reports and
Trustees Annual
Reports have been
submitted for 2020,
2021 and 2022.
CMF
governance
structure		 There was not a
formal governance
structure for CMF
at the start of 2023,
and no clear way to
hold the CEO
accountable.		 The CEO established
workstreams for charity
management. Trustees were
appointed as leads for each
workstream and now hold the
CEO accountable for
deliverables. Monthly board
meetings are minuted and
well attended. All Trustees
have read the Charity
Commission Essential
Trustee Guidelines.		 At future Annual
General Meetings a
review of the
governance structure
will take place.
Improvements will be
made following
recommendations to
suit the needs of the
charity.
Employee
based in the
UK		 Our CEO and sole
employee is based
in the UK and not
immediately
available to drive
progress on the
ground in
Zimbabwe.		 Our Launch Loan donor in
2023 generously sponsored 4
separate visits to Zimbabwe
for our CEO. During the visits
the CEO built trust and
rapport with local partners
and key contacts. By
communicating often via
meeting and messaging
platforms the CEO has been
able to maintain these
relationships to ensure
momentum in project setup is
maintained.		 Local researchers and
coordinators in
Zimbabwe have been
identified to run Project
Zambezi in
collaboration with our
partner organisations
when the initiative is
ready to launch. The
CEO has designed
robust monitoring and
evaluation processes to
ensure she will be able
to maintain oversight
over the projects from
abroad.

Impact

2023 was a year of restart and preparation for our upcoming charitable activities. As such we did not intend to measure a tangible impact for our beneficiaries. We intend to initiate Project Zambezi in 2024 and will be reporting on progress throughout the year.

8

Financial Overview

The accounts show a total income of £0 against an expenditure of £40,612.66. During this period, charitable expenditure was funded exclusively through an extension of the unrestricted ‘launch loan’ which had been provided to the charity on highly preferable terms by the charity’s founder and chairman.

Following a revitalisation of charity and project strategy, fundraising activities commenced in September 2023 with a focus on unrestricted grants and individual donor support. At the end of 2023, progress had been made on identifying suitable individuals and donors to support future charitable activities, although the efforts had not been reflected in income from any source.

Full details of income and expenditure are outlined at the end of this report in our financial statements (Appendix 1) and accounts (Appendix 2).

Income

Between 01[st] January and 31[st] December 2023 the charity did not receive income from any source.

Expenditure

During 2023 the Charity’s expenses totalled £40,612.66.

The principal expense was the salary of the CEO, totalling £30,295.19 (net), plus employer pension contributions of £2,825.13.

The CEO conducted three visits to Zimbabwe during the year. Travel and accommodation expenses for all three trips totalled £4,166.37.

Other expenditure included paying for legal advice, website upgrades and refreshments at meetings.

Due to significant delays in receiving the PAYE reference number from the contracted payroll service provider beyond the control of the charity, tax and NIC contributions could not be paid to HMRC for the year ending 31[st] December 2023.

A repayment plan for the sum of £25,227.52 was completed as agreed with HMRC.

Loans and debts

At the start of 2023 the Launch Loan stood at £72,116.94.

A further £40,726.25 was loaned to the charity in line with the existing loan agreement. This was used to pay for 2023 launch activity expenses.

At the end of 2023 the Launch Loan stood at £112,708.19.

Note to the 2023 Trustees Annual Report from February 2024

On 1[st] February 2024 the donor of the Launch Loan offered to convert the Launch Loan in its entirety to an unrestricted Launch Donation, so leaving the Charity debt free. This was reported to the Trustees at an Emergency Board Meeting on 5[th] February 2024.

9

Governance and Management

In 2023 Castlepines Medical Foundation underwent several changes to the way in which it was governed. The changes were designed to improve communication, compliance, visibility, and accountability within the Trustee team, and to identify and mitigate risks and conflicts of interest. There were no changes to the structure of the Trustee board, which is comprised of 5 members including an appointed Chair, Treasurer and Secretary. One new member of staff was appointed (CEO Lou Normand) and no volunteers joined the team.

Strategy: One of the first assignments undertaken by the new CEO was to revise the charity and project strategy based on findings from a landscape analysis in Zimbabwe, as well as bringing the charity reporting up-to-date with charity commission requirements.

Board meetings: There were 12 board meetings in 2023, of which 75% were quorate. Due to the need to vote on the changes to strategic direction and implement revised governance documents the board meeting frequency was increased to occur monthly. Board meeting minute taking was formalised, with the Secretary delegating to the Treasurer when unable to attend the meeting. At each meeting any new or changed conflicts of interest are now flagged by the Trustee team and are included in the meeting minutes.

Workstreams: To improve accountability within the Trustee team and to streamline board meetings, Trustees were appointed lead roles for ‘workstreams’ within the charity governance framework. The workstreams and associated leads are: governance (Tafadzwa Mugwagwa), compliance (Ken Ralston), fundraising (David Grose), finance (Dr Stan Shepherd), and marketing and communications (Neil Carpenter). The leads are accountable for the deliverables in their respective workstreams, though the responsibility for managing the deliverables was mostly delegated to the CEO. Workstream sub-committees were established in early 2024.

The changes have been reflected on our organogram:

Constitution: Updates to the constitution were voted on and approved at the board meeting on 29[th] June 2023. The updates to our charitable objects were to remove references to the State and to broaden our remit beyond the provision of medicines. Changes were formally recognised by the Charity Commission in January 2024.

10

Policies: Over the course of the year the CEO and Trustees formalised and enacted policies for Conflicts of Interest, Harassment, Risk Management, Safeguarding and Whistleblowing. The Employee Handbook was also revised and implemented in June 2023.

Future Plans

In 2024 we intend to launch both aspects of Project Zambezi, strengthen financial resilience, and to expand our team so that we can increase the reach of our lifesaving work.

However, these plans are highly influenced by the availability of funds, and as such the year will be begin with a concerted effort to generate financial support.

Recognition and Thanks

The enormous progress we have made with charity formalisation, strategy and project setup would not have been possible without the freely given advice and support from a number of incredibly generous individuals, experts and organisations.

All of us here at Castlepines Medical Foundation are grateful to our collaborators for helping us to reform into a responsible, organised charity with clarity of purpose and a very exciting first project. Those who deserve a particular thanks are as follows:

David Grose, for your incredibly generous financial support and ongoing commitment to Castlepines Medical Foundation.

Kate and Marc Garnett for facilitating our CEO’s visits to Zimbabwe through accommodation, food, transport, introductions, and many hours of advice.

Marius, Harvey, Anisa and Julius at Vistra for your help with our accounts and offer of administrative support.

Our partners at the Harare Institute of Public Health, World Health Organisation Zimbabwe office, Zimbabwean Ministry of Health and Child Care, Dr Musekiwa, Paul and the Olive development team for believing in our mission and helping us to refine our plans for Project Zambezi.

Another wave of thank yous to the following who have kindly provided their expert guidance in multiple forms over the last year:

11

There are plenty more individuals with whom we have had conversations which helped to shape our strategy. We are very appreciative for your time and assistance.

Appendix 1: Financial Summary

A summary of the Launch Loan and expenses for 2023 is set out in the table below.

All in £ Loan Expenses
Launch Loan Funds received in 2023 40,681.25
Expenses
Salary (30,295.19)
Travel and accommodation (4,166.37)
Refreshment (492.45)
Allianz Health Insurance (1,983.52)
NEST Pension (2,825.13)
Iris Payroll services (456.00)
Legal advice:Consultancy Fee (144.00)
Website (250.00)
Total expenses (40,612.66)
Bank balance 28 Dec 23 68.59
Income Tax and NIC (25,227.52)
Launch Loan balance
At end 2022 72,116.94
At end 2023 112,708.19

The Charity’s cash flow was managed as follows: as upcoming expenses were identified, and before they became due, the donor paid into the Charity’s bank account the necessary funds to meet those expenses.

Note that On 1st February 2024 the donor of the Launch Loan converted the Launch Loan in its entirety to an unrestricted Launch Donation, so leaving the Charity debt free.

12

Appendix 2: Annual Accounts

Date Transaction Payee Note Loan Expense
Loan
Castlepines Corporation Australia
17 Mar 2023 Castlepines Corporation Australia £7,000.00
4 May2023 Castlepines Corporation Australia £883.31
29 May2023 Castlepines Corporation Australia £10,000.00
18 Jul 2023 Castlepines Corporation Australia £13,050.00
16 Oct 2023 Castlepines Corporation Australia £492.45
30 Oct 2023 Castlepines Corporation Australia £1,126.90
8 Dec 2023 Castlepines Corporation Australia £4,383.59
17 Dec 2023 Castlepines Corporation Australia £3,745.00
Castlepines Corporation Australia Total £40,681.25
Expenses
Salary
31 Mar 2023 CEO Mar-23 (£3,000.00)
30 Apr 2023 CEO Apr-23 (£1,400.00)
3 May2023 CEO Apr-23 (£790.00)
30 May2023 CEO May23 adjusted for Mar,Apr 23 (£2,795.16)
1 Jul 2023 CEO Jun-23 (£3,311.75)
29 Jul 2023 CEO Jul-23 (£2,908.38)
29 Aug2023 CEO Aug-23 (£3,217.98)
28 Sep2023 CEO Sep-23 (£3,217.98)
30 Oct 2023 CEO Oct-23 (£3,217.98)
8 Dec 2023 CEO Nov-23 (£3,217.98)
27 Dec 2023 CEO Dec-23 (£3,217.98)
Salary Total (£30,295.19)
Employee Pension
6 Jun 2023 NEST Apr-23 (£256.83)
19 Jun 2023 NEST May-23 (£256.83)
16 Jul 2023 NEST Jun-23 (£256.83)
3 Aug2023 NEST Jul-23 (£1,027.32)
6 Sep2023 NEST Aug-23 (£256.83)
2 Oct 2023 NEST Sep-23 (£256.83)
6 Nov 2023 NEST Oct-23 (£256.83)
20 Dec 2023 NEST Nov-23 (£256.83)
Employee Pension Total (£2,825.13)
Employee Health Insurance
30 Apr 2023 Allianz May-23 (£201.60)
3 May2023 Allianz Mar,Apr 23 (£370.72)
21 Jun 2023 Allianz Jun-23 (£201.60)
23 Jul 2023 Allianz Jul-23 (£201.60)
17 Aug2023 Allianz Aug-23 (£201.60)
17 Sep2023 Allianz Sep-23 (£201.60)
17 Oct 2023 Allianz Oct-23 (£201.60)
17 Nov 2023 Allianz Nov-23 (£201.60)
18 Dec 2023 Allianz Dec-23 (£201.60)
Employee Health Insurance Total (£1,983.52)
Employee Travel, Accommodation and Subsistence
19 Mar 2023 CEO Test transfer (£10.00)
20 Mar 2023 CEO Zimbabwe Zambia expenses (£1,878.65)
5 Jun 2023 CEO Zimbabwe expenses (£739.67)
3 Jul 2023 CEO Zimbabwe visit Jun 23 (£395.00)
28 Aug2023 CEO Meet Dr Zamba x 2 (£46.44)
8 Dec 2023 CEO Nov-23 (£1,096.61)
Employee Travel, Accommodation and Subsistence Total (£4,166.37)
Payroll services
10 Apr 2023 IRIS Software Limited Apr-23 (£42.00)
21 Jun 2023 IRIS Software Limited Jun-23 (£69.00)
27 Jul 2023 IRIS Software Limited Jul-23 (£69.00)
28 Aug2023 IRIS Software Limited Aug-23 (£69.00)
24 Sep2023 IRIS Software Limited (£69.00)
22 Oct 2023 IRIS Software Limited Oct-23 (£69.00)
8 Dec 2023 IRIS Software Limited (£69.00)
Payroll services Total (£456.00)
Trustee Dinner
20 Oct 2023 Armyand NavyClub General Account Invoice No. 52884-29106 (£411.92)
20 Oct 2023 Armyand NavyClub General Account Invoice No. 52884-29106 (£80.53)
Trustee Dinner Total (£492.45)
Website
14 Jun 2023 Nick Kenyon (£250.00)
Website Total (£250.00)
Legal advice
10 Apr 2023 Interface Legal Advisory (£144.00)
Legal advice Total (£144.00)
Expenses Grand Total (£40,612.66)
Bank balance 28 Dec 23 68.59
Income Tax and NIC due (25,227.52)
Due to significant delays in receivingthe PAYE reference number from the contracted
payroll serviceprovider beyond the control of the Charity,tax and NIC contributions
could not bepaid to HMRC for theyear ending31stDecember 2023.
A repaymentplan for the sum of £25,227.52 was completed in 2024 as agreed with HMRC.
Launch Loan balance
At end 2022 72,116.94
At end 2023 112,708.19
The Launch Loan is interest free with no fixed term
Repayment is due at times and in amounts determined bythe trustees

Note

On 1st February 2024 the donor of the Launch Loan converted the Launch Loan in its entirety to an unrestricted Launch Donation, so leaving the Charity debt free.

13

Transaction Payee

Date

Loan

Castlepines Corporation Australia 17 Mar 2023 Castlepines Corporation Australia 4 May 2023 Castlepines Corporation Australia 29 May 2023 Castlepines Corporation Australia 18 Jul 2023 Castlepines Corporation Australia 16 Oct 2023 Castlepines Corporation Australia 30 Oct 2023 Castlepines Corporation Australia 8 Dec 2023 Castlepines Corporation Australia 17 Dec 2023 Castlepines Corporation Australia Castlepines Corporation Australia Total

Expenses

Salary
31 Mar 2023 CEO
30 Apr 2023 CEO
3 May 2023 CEO
30 May 2023 CEO
1 Jul 2023 CEO
29 Jul 2023 CEO
29 Aug 2023 CEO
28 Sep 2023 CEO
30 Oct 2023 CEO
8 Dec 2023 CEO
27 Dec 2023 CEO
Salary Total
Employee Pension
6 Jun 2023 NEST
19 Jun 2023 NEST
16 Jul 2023 NEST
3 Aug 2023 NEST
6 Sep 2023 NEST
2 Oct 2023 NEST
6 Nov 2023 NEST
20 Dec 2023 NEST
Employee Pension Total
Employee Health Insurance
30 Apr 2023 Allianz
3 May 2023 Allianz
21 Jun 2023 Allianz
23 Jul 2023 Allianz
17 Aug 2023 Allianz
17 Sep 2023 Allianz
17 Oct 2023 Allianz
17 Nov 2023 Allianz
18 Dec 2023 Allianz

Employee Health Insurance Total

Employee Travel, Accommodation and Subsistence
19 Mar 2023 CEO
20 Mar 2023 CEO
5 Jun 2023 CEO
3 Jul 2023 CEO
28 Aug 2023 CEO
8 Dec 2023 CEO
Employee Travel, Accommodation and Subsistence Total

Payroll services

Payroll services
10 Apr 2023 IRIS Software Limited
21 Jun 2023 IRIS Software Limited
27 Jul 2023 IRIS Software Limited
28 Aug 2023 IRIS Software Limited
24 Sep 2023 IRIS Software Limited
22 Oct 2023 IRIS Software Limited
8 Dec 2023 IRIS Software Limited
Payroll services Total
Trustee Dinner
20 Oct 2023 Army and Navy Club General Account
20 Oct 2023 Armyand NavyClub General Account
Trustee Dinner Total
Website
14 Jun 2023 Nick Kenyon
Website Total

Legal advice 10 Apr 2023 Interface Legal Advisory Legal advice Total

Expenses Grand Total

Bank balance 28 Dec 23 68.59

Income Tax and NIC due

Due to significant delays in receiving the PAYE reference number fr payroll service provider beyond the control of the Charity, tax and N could not be paid to HMRC for the year ending 31[st] December 2023 A repayment plan for the sum of £25,227.52 was completed in 202

Launch Loan balance

At end 2022 72,116.94
At end 2023 112,708.19

The Launch Loan is interest free with no fixed term Repayment is due at times and in amounts determined by the trust

NOTES

On 1[st] February 2024 the donor of the Launch Loan converted the L in its entirety to an unrestricted Launch Donation, so leaving the Ch Trustees do not claim travel or other expenses

Loan

Note

Expense

£7,000.00 £883.31 £10,000.00 £13,050.00 £492.45 £1,126.90 £4,383.59 £3,745.00 £40,681.25

Mar-23 (£3,000.00)
Apr-23 (£1,400.00)
Apr-23 (£790.00)
May 23 adjusted for Mar, Apr 23 (£2,795.16)
Jun-23 (£3,311.75)
Jul-23 (£2,908.38)
Aug-23 (£3,217.98)
Sep-23 (£3,217.98)
Oct-23 (£3,217.98)
Nov-23 (£3,217.98)
Dec-23 (£3,217.98)
(£30,295.19)
Apr-23 (£256.83)
May-23 (£256.83)
Jun-23 (£256.83)
Jul-23 (£1,027.32)
Aug-23 (£256.83)
Sep-23 (£256.83)
Oct-23 (£256.83)
Nov-23 (£256.83)
(£2,825.13)
May-23 (£201.60)
Mar, Apr 23 (£370.72)
Jun-23 (£201.60)
Jul-23 (£201.60)
Aug-23 (£201.60)
Sep-23 (£201.60)
Oct-23 (£201.60)
Nov-23 (£201.60)
Dec-23 (£201.60)
(£1,983.52)
Test transfer (£10.00)
Zimbabwe Zambia expenses (£1,878.65)
Zimbabwe expenses (£739.67)
Zimbabwe visit Jun 23 (£395.00)
Meet Dr Zamba x 2 (£46.44)
Nov-23 (£1,096.61)
(£4,166.37)
Apr-23 (£42.00)
Jun-23 (£69.00)
Jul-23 (£69.00)
Aug-23 (£69.00)
(£69.00)
Oct-23 (£69.00)
(£69.00)
(£456.00)
Invoice No. 52884-29106 (£411.92)
Invoice No. 52884-29106 (£80.53)
(£492.45)
(£250.00)
(£250.00)
(£144.00)
(£144.00)
(£40,612.66)

-25,227.52

rom the contracted

NIC contributions

24 as agreed with HMRC.

tees

Launch Loan harity debt free.

Date Chk # Transaction Payee (Income) Castlepines Medical Foundation:Expenses (Begin) 19 Mar 2023 Louise Elizabeth Normand 20 Mar 2023 Louise Elizabeth Normand 5 Jun 2023 Louise Elizabeth Normand 3 Jul 2023 Louise Elizabeth Normand Castlepines Medical Foundation:Expenses Total Castlepines Medical Foundation:Expenses:Travel (Begin) 28 Aug 2023 Louise Elizabeth Normand 8 Dec 2023 Louise Elizabeth Normand Castlepines Medical Foundation:Expenses:Travel Total Castlepines Medical Foundation:Pension (Begin) 6 Jun 2023 NEST 19 Jun 2023 NEST 16 Jul 2023 NEST 3 Aug 2023 NEST 6 Sep 2023 NEST 2 Oct 2023 NEST 6 Nov 2023 NEST 20 Dec 2023 NEST Castlepines Medical Foundation:Pension Total Castlepines Medical Foundation:Salary (Begin) 31 Mar 2023 Louise Elizabeth Normand 30 Apr 2023 Louise Elizabeth Normand 3 May 2023 Louise Elizabeth Normand 30 May 2023 Louise Elizabeth Normand 1 Jul 2023 Louise Elizabeth Normand 29 Jul 2023 Louise Elizabeth Normand 29 Aug 2023 Louise Elizabeth Normand 28 Sep 2023 Louise Elizabeth Normand 30 Oct 2023 Louise Elizabeth Normand 8 Dec 2023 Louise Elizabeth Normand 27 Dec 2023 Louise Elizabeth Normand Castlepines Medical Foundation:Salary Total CMF:Expenses:Dinner (Begin) 20 Oct 2023 Army and Navy Club General Account CMF:Expenses:Dinner Total CMF:VAT (Begin) 20 Oct 2023 Army and Navy Club General Account CMF:VAT Total Health Insurance (Begin) 30 Apr 2023 Allianz 3 May 2023 Allianz 21 Jun 2023 Allianz

23 Jul 2023 Allianz 17 Aug 2023 Allianz 17 Sep 2023 Allianz 17 Oct 2023 Allianz 17 Nov 2023 Allianz 18 Dec 2023 Allianz Health Insurance Total Legal adviceConsultancy Fee (Begin) 10 Apr 2023 Interface Legal Advisory Legal adviceConsultancy Fee Total Loan:Castlepines Corporation Australia (Begin) 17 Mar 2023 Castlepines Corporation Australia 3 May 2023 CBA 29 May 2023 Castlepines Corporation Australia 18 Jul 2023 Castlepines Corporation Australia 16 Oct 2023 Castlepines Corporation Australia 30 Oct 2023 Castlepines Corporation Australia 8 Dec 2023 Castlepines Corporation Australia 17 Dec 2023 Castlepines Corporation Australia Loan:Castlepines Corporation Australia Total Payroll services (Begin) 10 Apr 2023 IRIS Software Limited 21 Jun 2023 IRIS Software Limited 27 Jul 2023 IRIS Software Limited 28 Aug 2023 IRIS Software Limited 24 Sep 2023 IRIS Software Limited 22 Oct 2023 IRIS Software Limited 8 Dec 2023 IRIS Software Limited Payroll services Total Reconciled with online statement (Begin) 7 Apr 2023 21 Apr 2023 30 Apr 2023 28 May 2023 30 May 2023 11 Jun 2023 18 Jun 2023 25 Jun 2023 1 Jul 2023 7 Jul 2023 23 Jul 2023 11 Aug 2023 1 Sep 2023 23 Sep 2023

ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<<

29 Sep 2023 7 Oct 2023 21 Oct 2023 3 Nov 2023 10 Nov 2023 20 Nov 2023 9 Dec 2023 22 Dec 2023 Reconciled with online statement Total Website (Begin) 14 Jun 2023 Website Total

ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<< ADJUSTMENT Interim <<<<<<<<<<<<<<<<<<<

Nick Kenyon

Note

Memo

Test transfer Zimbabwe Zambia expenses Zimbabwe expenses Zimbabwe visit Jun 23

Winchester Expenses x 2 to meet Dr Zamba Nov-23 Apr-23 May-23 Jun-23 Jul-23 Aug-23 Sep-23 Oct-23 Nov-23 Mar-23 Apr-23 Apr-23 May 23 adjusted for Mar, Apr 23 Jun-23 Jul-23 Aug-23 Sep-23 Oct-23 Nov-23 Dec-23 Invoice No. 52884-29106 Invoice No. 52884-29106 May-23 Mar, Apr 23 Jun-23

Jul-23 Aug-23 Sep-23 Oct-23 Nov-23 Dec-23

Castlepines

Apr-23 Jun-23 Jul-23 Aug-23 Oct-23 2.111.35 1925.35 323.75 46.34 7251.18 6254.68 6004.68 5477.25 2165.5 1770.5 14362.07 10357.37 6822.35 6363.92

3076.94 2820.11 2618.51 458.43 201.6 3286.57

Category Account Amount
Castlepines Medical Foundation:Expenses CMF £ Wise (£10.00)
Castlepines Medical Foundation:Expenses CMF £ Wise (£1,878.65)
Castlepines Medical Foundation:Expenses CMF £ Wise (£739.67)
Castlepines Medical Foundation:Expenses CMF £ Wise (£395.00)
(£3,023.32)
Castlepines Medical Foundation:Expenses:Travel CMF £ Wise (£46.44)
Castlepines Medical Foundation:Expenses:Travel CMF £ Wise (£1,096.61)
(£1,143.05)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£1,027.32)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
Castlepines Medical Foundation:Pension CMF £ Wise (£256.83)
(£2,825.13)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,000.00)
Castlepines Medical Foundation:Salary CMF £ Wise (£1,400.00)
Castlepines Medical Foundation:Salary CMF £ Wise (£790.00)
Castlepines Medical Foundation:Salary CMF £ Wise (£2,795.16)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,311.75)
Castlepines Medical Foundation:Salary CMF £ Wise (£2,908.38)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,217.98)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,217.98)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,217.98)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,217.98)
Castlepines Medical Foundation:Salary CMF £ Wise (£3,217.98)
(£30,295.19)
CMF:Expenses:Dinner CMF £ Wise (£411.92)
(£411.92)
CMF:VAT CMF £ Wise (£80.53)
(£80.53)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£370.72)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
Health Insurance CMF £ Wise (£201.60)
(£1,983.52)
Legal adviceConsultancy Fee CMF £ Wise (£144.00)
(£144.00)
Loan:Castlepines Corporation Australia CMF £ Wise £7,000.00
Loan:Castlepines Corporation Australia CMF A$ Wise £935.35
Loan:Castlepines Corporation Australia CMF £ Wise £10,000.00
Loan:Castlepines Corporation Australia CMF £ Wise £13,050.00
Loan:Castlepines Corporation Australia CMF £ Wise £492.45
Loan:Castlepines Corporation Australia CMF £ Wise £1,126.90
Loan:Castlepines Corporation Australia CMF £ Wise £4,383.59
Loan:Castlepines Corporation Australia CMF £ Wise £3,745.00
£40,733.29
Payroll services CMF £ Wise (£42.00)
Payroll services CMF £ Wise (£69.00)
Payroll services CMF £ Wise (£69.00)
Payroll services CMF £ Wise (£69.00)
Payroll services CMF £ Wise (£69.00)
Payroll services CMF £ Wise (£69.00)
Payroll services CMF £ Wise (£69.00)
(£456.00)
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
Reconciled with online statement CMF £ Wise £0.00
£0.00
Website CMF £ Wise (£250.00)
(£250.00)